U.S. regulator approves Teva migraine drug, shares rise | Reuters
Teva pushes further into transdermal patches with $144M NuPathe buy
Teva hopes to launch migraine drug as soon as September | Reuters
Teva's Israeli Plant Receives FDA Stamp of Approval for Migraine Drug Manufacturing | Ctech
EMHA and Teva, Migraine day of Action
Teva Canada Announces New Autoinjector for AJOVY® for the Preventive Treatment of Migraine in Adults | Business Wire
Teva stops selling migraine patches after reports of burns | The Times of Israel
No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds | FiercePharma
Teva Pharmaceutical Industries Ltd. - Our research has uncovered the extraordinarily disproportionate impact #migraine has on women than men. Meet Ciara and others – the real people behind the numbers – and
Teva Wins Appeal That Upholds Three Patents for Migraine Drug
Will Teva's migraine drug help the company overcome its headaches? - STAT
Faint hope for Alder as Teva bucks dismal migraine trend | Evaluate
Teva scraps Heptares migraine pact as lead drug nears clinic | FierceBiotech
Showcasing Teva's Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY® (fremanezumab-vfrm) Injection at the International Headache Society and European Headache... | Business
Can Teva Hold Its Own In Bringing Migraine Drugs To Market? | Investor's Business Daily
Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet
Teva migraine medicine gets EU positive opinion
Xconomy: Teva Seeks to Keep Pace in Migraine Drug Race With Trial Results
Teva tries to make something out of nothing with Ajovy approval | Evaluate
Teva's migraine prophylaxis drug now approved in Europe
Teva Pharmaceutical: Shares rise after FDA approves new migraine drug | Business News,The Indian Express
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug | BioSpace
Ajovy, Teva's migraine drug, recommended by UK's NICE.
Beyond Migraine
TEVA: Announces FDA Approval of AJOVY® (fremanezumab-vfrm) Injection Autoinjector | FDA Health News
